Aster Neurosciences Bangalore organizes Walkathon to mark "World Parkinson's Day"
Bangalore: (Press Release) Aster Neurosciences of Aster CMI hospital and Aster RV hospital, Bangalore marked the World Parkinson’s Day on Monday by organising a walkathon in partnership with I Love To Care (India) Charitable Trust.
More than 150 people including Parkinson’s patients, working professionals, doctors, and nurses participated in the walkathon to raise awareness against Parkinson’s.
Dr. Kalpana Gopalan, IAS, Additional Chief Secretary, Dept of Labour & Dept of Public Grievances, Govt. of Karnataka who participated in the event as the Chief Guest flagged off the event and also took part in the walkathon to support the cause.
“Parkinson's disease is a neurodegenerative disorder. It begins gradually and deteriorates over the long run. Those suffering from Parkinson’s disease exhibit symptoms such as shaking of limbs, muscle stiffness, and trouble walking and maintaining their balance and coordination. As the disease worsens, they additionally experience difficulty in talking, disturbance of sleep, problems with memory, psychological issues, behavioral changes, and various other side effects,” an official press statement from Aster stated.
Addressing the audience and the need to create awareness about Parkinson’s disease, Dr. Kalpana Gopalan, IAS, Additional Chief Secretary, Dept of Labour & Dept of Public Grievances, Govt. of Karnataka chief guest at the event, said, “We want everyone - patients, families, and society - to understand that Parkinson's disease is treatable and manageable. However, considering the increasing prevalence of Parkinson's disease, there is a need to create awareness about Parkinsonism and foster a sense of public urgency. In India, ignorance and misinformation may be barriers to the early diagnosis and the provision of optimal care to those living with the disease. Keeping this in mind, Aster Hospital has organized this Walkathon to raise awareness about this degenerative yet treatable brain disorder. I thank Aster for inviting me to be a part of this event and appreciate everyone present here today.”
Dr. Ravi Gopal Varma, Lead Consultant Neurosurgery & Program Director – Global Centre of Excellence in Neurosciences, Aster Hospitals Bangalore, said: “India is home to about 10 lakhs Parkinson's patients, and every year 75,000 new patients are diagnosed with this condition. The disease predominately affects the elderly those aged 60 years and above. However, now it can also be seen in younger generations as well. Parkinson's disease, fortunately, has a successful treatment. The medical treatment along with Deep Brain Stimulation (DBS) has brought about a revolution in the management of Parkinson's disease, enabling the patient to live a normal and dynamic life. DBS is a functional surgery where electrodes are placed in specific areas of the patient’s brain and stimulated with the help of a pacemaker placed in the chest wall. In this case, the pacemaker is unique as it has the capability to receive feedback from the brain and relay the exact amount of stimulation on demand to the implanted electrodes for the brain to function accordingly. As the patient begins to show signs of improvement, the medications are reduced. The surgery is highly beneficial in alleviating the symptoms of Parkinson’s disease and reducing the patient's dependence on medicines.”
About Aster DM Healthcare
Aster DM Healthcare Limited is one of the largest private healthcare service providers operating in GCC and in India. With an inherent emphasis on clinical excellence, we are one of the few entities in the world with a strong presence across primary, secondary, tertiary, and quaternary healthcare through our 27 hospitals, 118 clinics, 323 pharmacies, and 66 labs & patient experience centres in seven countries, including India. We have over 24,350 plus dedicated staff including 3,110 doctors and 7,063 nurses across the geographies that we are present in, delivering a simple yet strong promise to our different stakeholders: "We'll treat you well." We reach out to all economic segments in the GCC states through our differentiated healthcare services across the "Aster", "Medcare" and "Access" brands.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Rupee strengthens past 90/USD level in early trade
Mumbai (PTI): The rupee appreciated 24 paise to 89.96 against the US dollar in early trade on Friday, supported by corporate dollar inflows and easing crude oil prices.
Forex traders said the gain in the USD/INR pair follows the rupee’s string of record lows in recent weeks on likely intervention from the Reserve Bank of India.
Moreover, crude oil prices hovering around USD 59 per barrel level supported market sentiment.
ALSO READ:Rupee trades in narrow range against US dollar in early trade
At the interbank foreign exchange market, the rupee opened at 90.19 against the US dollar, then gained some ground and touched 89.96 against the US dollar, registering a gain of 24 paise over its previous close.
In initial trade it also touched 90.22 against the American currency. On Thursday, the rupee appreciated 18 paise against the US dollar to close at 90.20 against the greenback.
The rupee sank to a fresh record low, breaching the 91-a-dollar mark for the first time on Tuesday.
"Since the speculators are out of the market the buying of US dollar syndrome has come down a bit though intra-day we could see spikes," said Anil Kumar Bhansali Head of Treasury and Executive Director Finrex Treasury Advisors LLP.
The US CPI came lower than expected but was also due to non-collection of sufficient data and therefore, the next month’s CPI becomes more important, Bhansali said, adding that "Rupee remains in a range of 90-90.50".
Meanwhile, the dollar index, which gauges the greenback's strength against a basket of six currencies, was trading 0.04 per cent higher at 98.46.
Brent crude, the global oil benchmark, was trading lower by 0.27 per cent at USD 59.66 per barrel in futures trade.
On the domestic equity market front, the 30-share benchmark index Sensex climbed 375.98 points to 84,857.79, while the Nifty was up 110.60 points to 25,934.15.
Foreign Institutional Investors purchased equities worth Rs 595.78 crore on Thursday, according to exchange data.
Meanwhile, Economic Advisory Council to the Prime Minister (EAC-PM) member Sanjeev Sanyal on Thursday said he is not concerned about the rupee at all, arguing that even China and Japan witnessed exchange rate weaknesses during their high growth phases.
Speaking at 'Times Network's India Economic Conclave 2025', Sanyal said since the 90s, the rupee has mostly been allowed to find its own level, but the RBI uses its reserves to intervene in either direction to stop excessive volatility.
"I am not concerned about the rupee at all... Let me say that the rupee and its current weakness should not be necessarily conflated with some economic worry, because historically, if you go over time, you will see that economies that are in their high growth phase very often go through a phase of exchange rate weakness," he said.
